date,title,source
Oct-17-18,Albireo Receives FDA Fast Track Designation for A4250,GlobeNewswire
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-08-18,Albireo to Present at Investor Conferences in November,GlobeNewswire
Nov-13-18,Albireo Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-18-18,Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia,GlobeNewswire
Feb-07-19,"How Financially Strong Is Albireo Pharma, Inc. (NASDAQ:ALBO)?",Simply Wall St.
Feb-25-19,"New Research Coverage Highlights Starbucks, Cheetah Mobile, Seagate Technology, Momo, Albireo Pharma, and Essent Group  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Feb-28-19,Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC),GlobeNewswire
Mar-04-19,Albireo to Present at Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-07-19,"Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Mar-07-19,Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update,GlobeNewswire
Mar-21-19,Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer,GlobeNewswire
Mar-27-19,Albireo to Present Clinical Data on A4250 in Alagille Syndrome and Biliary Atresia at The International Liver Congress 2019,GlobeNewswire
Apr-01-19,Albireo to Present at Investor Conferences in April,GlobeNewswire
Apr-11-19,Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH,GlobeNewswire
May-02-19,Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast,GlobeNewswire
May-09-19,"Albireo Pharma, Inc. (ALBO) Q1 2019 Earnings Call Transcript",Motley Fool
May-23-19,Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting,GlobeNewswire
